Data for AI / AI Licensing
Give your AI better pharma and biotech data to work with
Build AI applications using specialist pharma and biotech intelligence that goes beyond publicly available information.
License Evaluate’s expert-curated and harmonized data across products, indications, sales, forecasts and more. Bring structured, proprietary intelligence into your AI applications, models and internal workflows, backed by established methodology and specialist pharma expertise.
Why better data matters for your AI
Start with the question that matters most to you. Each tile takes you to the full answer below.
Better data
Why specialist pharma questions need more than public information.
What you can build
Four types of AI application Evaluate data can support.
A clearer view
How structured data helps you compare opportunities consistently.
AI licensing
Licensing options shaped by how your application uses the data.
Your AI environment
Delivery through Snowflake, structured feeds and selected APIs.
Get started
Three steps from your use case to agreed access.
The Evaluate data difference
Data for AI
Tell us what you’re developing, and our team can help you explore the relevant datasets, delivery options and licensing arrangements for your project.
Better AI starts with better data
AI can synthesize information, identify patterns and support increasingly complex analysis. But the quality of its outputs depends on the information available to it.
General-purpose AI can draw on extensive public information. However, specialist pharma and biotech questions often require greater depth, consistency and domain-specific context.
Evaluate provides expert-curated, harmonized and proprietary intelligence built specifically for pharma and biotech analysis. Our data combines structured information with established methodologies and specialist analyst expertise, giving approved AI and machine-learning applications more reliable inputs for complex industry questions.
Public information can provide:
Company announcements and disclosures
High-level clinical trial information
Published financial information
News and publicly available market information
Evaluate data adds
Structured product and company attributes
Historical and projected product sales
Indication-level sales and commercial opportunity
Development timelines and probability of success
Company, deal and competitive intelligence
Established forecasting methodology and specialist analyst input
Give your AI access to the deeper market context needed to support specialist analysis.
What can you build with Evaluate data?
Integrate Evaluate datasets into your existing AI environment to support applications built around the questions your teams need to answer.
Internal AI assistants and knowledge platforms
Ground internal AI assistants and knowledge tools in licensed Evaluate intelligence alongside your organization’s proprietary information, supporting research, search and knowledge management within your existing environment.
Give your AI applications access to structured external data alongside internal sources, helping teams explore company, product, pipeline and market information within a connected environment.
Predictive analytics and machine learning
Incorporate relevant commercial, product and development data into predictive models.
Explore potential market outcomes, identify patterns across historical data and support forecasting, portfolio analysis and scenario modelling.
Asset screening and opportunity identification
Use structured product, company, deal and pipeline intelligence to support AI-enabled screening and prioritization.
Combine Evaluate data with your own criteria and proprietary information to help identify assets, companies and potential partnering or investment opportunities.
Competitive intelligence and horizon scanning
Programmatically monitor updates across products, indications, companies and markets to explore competitive developments and emerging opportunities.
Bring together relevant datasets to help your teams assess changes in the landscape, inform impact analysis and inform strategic decisions.
From fragmented information to a clearer view of opportunity
Consider an AI application designed to answer a strategic question:
“Which opportunities across the pharma and biotech landscape best match our strategic priorities?”
Answering that question requires an application to compare products, indications, companies and development activity across several factors. Commercial potential is one part of the picture. Development risk, timing, company context and transaction activity can all affect how an opportunity is assessed.
Public sources can provide individual pieces of information through company announcements, clinical trial updates and financial disclosures. The challenge is bringing those signals together in a structured and consistent way so they can be compared across a wider market.
Evaluate data provides inputs to support that analysis:
You can combine these external data points with your own criteria, such as target therapy areas, development stage or commercial requirements.
This gives AI applications structured pharma and biotech data to screen a wider landscape, compare opportunities more consistently and help teams identify where further investigation may be worthwhile.
AI data licensing designed around your use case
Evaluate offers licensing options for organizations looking to use its proprietary pharma and biotech data within approved AI-enabled systems and applications.
Whether you’re developing an internal AI assistant, building predictive models or integrating AI into existing business workflows, the appropriate licensing arrangement will depend on how the data is being used.
This includes considerations such as:
Which Evaluate datasets will be used within the application.
Whether data will be used to inform, train or support AI models.
Who will have access to the application and its outputs.
Whether usage is limited to an individual team or extends across multiple departments.
How the data will be integrated and made available within your environment.
Our team can help establish the appropriate data access, delivery and usage rights for your intended application.
Your AI environment, enhanced with Evaluate intelligence.
You don’t need to build your AI strategy around a separate data platform.
You can incorporate Evaluate data into your existing infrastructure, allowing you to combine specialist external intelligence with your own proprietary information and other approved sources.
Relevant datasets can be delivered through supported delivery options, including Snowflake, structured data feeds and selected APIs.
Whether you’re developing an internal research assistant or building a predictive analytics workflow, the objective is the same: give your applications access to relevant pharma and biotech intelligence within your existing environment.
Bring Evaluate data into your AI project
Exploring how Evaluate intelligence could support your AI application? Our team can help identify the relevant data and licensing approach.
Tell us what you’re building
Share your intended AI use case, the questions you’re trying to answer and how your application will be used.
Identify the right datasets
Explore the Evaluate data that could support your project, including relevant product, commercial, company and development intelligence.
Request sample data to assess the structure and suitability for your requirements.
Agree access and usage rights
Work with our team to establish the appropriate licensing and delivery arrangements for your application.
Build your next AI application on better data
Give your AI applications access to expert-curated pharma and biotech intelligence, with established methodology and specialist expertise behind it.
Tell us what you’re developing, and our team can help you explore the relevant datasets, delivery options and licensing arrangements for your project.
Tell us what data you need
Tell us briefly about the question, workflow or problem you are trying to solve.
Not sure which datasets you need? Tell us what you are trying to solve, and we can help identify the right options.
Common questions
Frequently Asked Questions
What is Evaluate AI data licensing?
Evaluate AI data licensing enables organizations to incorporate selected proprietary pharma and biotech datasets into approved AI and machine-learning applications. Available usage rights depend on the intended application, its users and how the resulting outputs will be used.
Can Evaluate data be used to train AI models?
Evaluate offers licensing options for AI-related use cases, including the use of data to inform or train models where appropriate rights have been agreed. Model training and other intended applications should be discussed with our team to establish the relevant permissions.
Can we combine Evaluate data with our own proprietary information?
Yes. Evaluate data can be incorporated alongside internal and approved third-party sources within supported AI and analytical environments.
Do we need AI licensing if we already subscribe to Evaluate?
Your existing subscription may not cover every type of AI integration or usage. Incorporating Evaluate data into an AI application serving multiple users or systems can require additional permissions. Our team can help establish the appropriate licensing arrangement for your intended use.
How is Evaluate data delivered for AI applications?
Available delivery options include Snowflake data sharing, structured flat-file delivery and selected APIs. The appropriate method depends on your chosen datasets, technical environment and application requirements.
Can we access sample data before committing to a license?
Yes. Representative sample data is available on request, allowing you to review the structure, available fields and relevance of selected datasets before discussing the next steps.
